A Prospective, Randomized, Controlled Trial Comparing the Effects of Noncontact, Low-frequency Ultrasound to Standard Care in Healing Venous Leg Ulcers

被引:1
作者
Gibbons, Gary W. [1 ,2 ]
Orgill, Dennis P. [3 ,4 ]
Serena, Thomas E. [5 ]
Novoung, Aksone [6 ,7 ]
O'Connell, Jessica B. [8 ,9 ]
Li, William W. [10 ,11 ,12 ,13 ]
Driver, Vickie R.
机构
[1] South Shore Hosp, Ctr Wound Healing, Weymouth 02189, MA USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Serena Grp Wound Care Ctr, Cambridge, MA USA
[6] Univ Calif Los Angeles, Dept Veteran Affairs Greater, Dept Podiatr Surg, Los Angeles, CA USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Dept Vasc Surg, Los Angeles, CA 90095 USA
[8] UCLA, Greater Angeles Vet Adm Med Ctr, Vasc Surg Serv, Los Angeles, CA USA
[9] Univ Calif Los Angeles, Dept Surg, Gonda Gold Schmied Vasc Ctr, Los Angeles, CA 90024 USA
[10] Angiogenesis Fdn, Cambridge, MA USA
[11] VA New England Hlth Care Div, Providence, RI USA
[12] Brown Univ, Sch Med, Providence, RI 02912 USA
[13] HBO & Wound Healing Ctr Rhode Island Hosp, Providence, RI 02912 USA
关键词
randomized controlled trial; leg ulcer; ultrasound therapy; wound healing; pain; QUALITY-OF-LIFE; STASIS ULCERS; LONG-TERM; THERAPY; FOOT; VALIDATION; GUIDELINES; DISEASE; WOUNDS; CANCER;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Current scientific evidence suggests venous leg ulcers (VLUs) that do not respond to guideline-defined care may have a wound microenvironment that is out of physiological balance. A prospective, randomized, controlled, multicenter trial was conducted to compare percent wound size reduction, proportions healed, pain, and quality-of-life (QOL) outcomes in patients randomized to standard care (SC) alone or SC and 40 kHz noncontact, low-frequency ultrasound (NLFU) treatments 3 times per week for 4 weeks. One hundred, twelve (112) eligible participants with documented venous stasis, a VLU >30 days' duration, measuring 4 cm(2) to 50 cm(2), and demonstrated arterial flow were enrolled. Of these, 81 reduced <30% in size during the 2-week run-in study phase and were randomized (SC, n = 40; NLFU+SC, n = 41). Median age of participants was 59 years; 83% had multiple complex comorbidities. Index ulcers were 56% recurrent, with a median duration of 10.3 months (range 1 month to 204.5 Months) and median ulcer area of 11.0 cm(2) (range 3.7 cm(2)-41.3 cm(2)). All participants received protocol-defined SC compression (30-40 mm Hg), dressings to promote a moist wound environment, and sharp debridement at the bedside for a minimum of 1 time per week. Ulcer measurements were obtained weekly using digital planimetry. Pain and QOL scores were assessed at baseline and after 4 weeks of treatment using the Visual Analog Scale and the Short Form-36 Health Survey. After 4 weeks of treatment, average wound size reduction was 61.6% +/- 28.9 in the NLFU+SC compared to 45% +/- 32.5 in the SC group (P = 0.02). Reductions in median (65.7% versus 44.4%, P = 0.02) and absolute wound area (9.0 cm(2) versus 4.1 cm(2), P = 0.003) as well as pain scores (from 3.0 to 0.6 versus 3.0 to 2.4, P = 0.01) were also significant. NLFU therapy with guideline-defined standard VLU care should be considered for healing VLUs not responding to SC alone. The results of this study warrant further research on barriers to healing and the changes occurring in the tissue of the wound to explore theories that the microenvironment impacts wounds that do not heal despite provision of guideline-defined care.
引用
收藏
页码:16 / 29
页数:14
相关论文
共 45 条
  • [41] Health-related quality of life in female long-term colorectal cancer survivors
    Trentham-Dietz, A
    Remington, PL
    Moinpour, CM
    Hampton, JM
    Sapp, AL
    Newcomb, PA
    [J]. ONCOLOGIST, 2003, 8 (04) : 342 - 349
  • [42] US Food and Drug Administration, 1998, GUID IND E9 STAT PRI
  • [43] US Food and Drug Administration Center for Devices and Radiological Health, 2005, CELL MIST THER SYST
  • [44] Ware J.E., 2008, SF-36v2 Health Survey: Administration Guide for Clinical Trial Investigators
  • [45] A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers
    Yao, Min
    Hasturk, Hatice
    Kantarci, Alpdogan
    Gu, Guosheng
    Garcia-Lavin, Silvia
    Fabbi, Matteo
    Park, Nanjin
    Hayashi, Hisae
    Attala, Khaled
    French, Michael A.
    Driver, Vickie R.
    [J]. INTERNATIONAL WOUND JOURNAL, 2014, 11 (06) : 586 - 593